[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Merck & Company (MRK)

Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 295,687,328
  • Shares Outstanding, K 2,469,824
  • Annual Sales, $ 65,011 M
  • Annual Income, $ 18,254 M
  • EBIT $ 12,969 M
  • EBITDA $ 18,807 M
  • 60-Month Beta 0.18
  • Price/Sales 4.65
  • Price/Cash Flow 10.72
  • Price/Book 6.58

Options Overview Details

View History
  • Implied Volatility 30.78% (-0.91%)
  • Historical Volatility 30.51%
  • IV Percentile 61%
  • IV Rank 49.96%
  • IV High 39.92% on 05/30/25
  • IV Low 21.66% on 12/08/25
  • Expected Move (DTE 2) 2.79 (2.30%)
  • Put/Call Vol Ratio 1.12
  • Today's Volume 9,776
  • Volume Avg (30-Day) 24,812
  • Put/Call OI Ratio 0.93
  • Today's Open Interest 513,231
  • Open Int (30-Day) 504,644
  • Expected Range 118.43 to 124.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.11
  • Number of Estimates 4
  • High Estimate $2.18
  • Low Estimate $2.02
  • Prior Year $2.13
  • Growth Rate Est. (year over year) -0.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
107.90 +11.97%
on 04/29/26
123.13 -1.88%
on 05/26/26
+10.59 (+9.61%)
since 04/27/26
3-Month
107.90 +11.97%
on 04/29/26
124.00 -2.56%
on 04/09/26
-3.00 (-2.42%)
since 02/27/26
52-Week
75.40 +60.24%
on 06/02/25
125.14 -3.45%
on 02/25/26
+43.23 (+55.72%)
since 05/27/25

Most Recent Stories

More News
Merck Announces Third-Quarter 2026 Dividend

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.85 per share of the company’s common stock...

MRK : 120.77 (+0.88%)
Amylyx Stock: Why the Full Pipeline Story Matters

Amylyx stock has surged on pipeline progress, but investors should understand the risks and long-term catalysts driving AMLX shares

AMLX : 14.05 (+2.70%)
MRK : 120.77 (+0.88%)
REGN : 629.78 (-0.76%)
Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio.

Go beyond the broad index and find which segment of healthcare best suits your portfolio needs now.

XLV : 148.92 (+0.28%)
$SPX : 7,514.83 (-0.06%)
MRK : 120.77 (+0.88%)
LLY : 1,082.15 (+1.64%)
PPH : 105.05 (+0.88%)
IHI : 49.31 (-2.10%)
UNH : 381.37 (+1.20%)
ELV : 389.24 (+0.36%)
PFE : 26.21 (+1.39%)
Stocks Settle Higher on Iran Peace Hopes and Tech Strength

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.37%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.42%. June E-mini S&P...

AMAT : 444.61 (-2.26%)
INTU : 312.71 (+2.75%)
ADI : 413.94 (-1.43%)
DDOG : 220.53 (-1.40%)
MRK : 120.77 (+0.88%)
TXN : 314.37 (-3.24%)
$IUXX : 29,914.55 (-0.29%)
COIN : 175.43 (-2.54%)
ASML : 1,590.96 (-2.52%)
ZNM26 : 109-285 (+0.06%)
ESM26 : 7,529.00 (-0.11%)
QCOM : 226.93 (-8.80%)
Stocks Climb on US-Iran Peace Hopes and Strength in Chipmakers

The S&P 500 Index ($SPX ) (SPY ) today is up +0.50%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.73%. June E-mini S&P futures (ESM26...

AMAT : 444.61 (-2.26%)
INTU : 312.71 (+2.75%)
ADI : 413.94 (-1.43%)
DDOG : 220.53 (-1.40%)
MRK : 120.77 (+0.88%)
TXN : 314.37 (-3.24%)
$IUXX : 29,914.55 (-0.29%)
ASML : 1,590.96 (-2.52%)
ZNM26 : 109-285 (+0.06%)
ESM26 : 7,529.00 (-0.11%)
QCOM : 226.93 (-8.80%)
IBM : 255.61 (+1.96%)
TSX Opens Higher on Good Vibes from Peace Talks

Canada's main stock index opened higher on Friday, as investors watched for signs of a breakthrough ...

MRK : 120.77 (+0.88%)
TSX Opens Higher on Good Vibes from Peace Talks

Canada's main stock index ?opened higher on Friday, as investors watched for signs of a breakthrough ...

MRK : 120.77 (+0.88%)
Stocks Supported by US-Iran Peace Deal Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.54%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.53%. June E-mini S&P futures (ESM26...

AMAT : 444.61 (-2.26%)
INTU : 312.71 (+2.75%)
ADI : 413.94 (-1.43%)
DDOG : 220.53 (-1.40%)
MRK : 120.77 (+0.88%)
TXN : 314.37 (-3.24%)
$IUXX : 29,914.55 (-0.29%)
ASML : 1,590.96 (-2.52%)
ZNM26 : 109-285 (+0.06%)
MSFT : 412.40 (-0.87%)
ESM26 : 7,529.00 (-0.11%)
QCOM : 226.93 (-8.80%)
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer

Opinion granted based on positive event-free survival, overall survival and pathologic complete response rate results from the Phase 3 KEYNOTE-905 trial If approved, this...

MRK : 120.77 (+0.88%)
2 Reasons to Watch MRK and 1 to Stay Cautious

2 Reasons to Watch MRK and 1 to Stay Cautious

MRK : 120.77 (+0.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda,...

See More

Key Turning Points

3rd Resistance Point 125.82
2nd Resistance Point 124.47
1st Resistance Point 122.10
Last Price 120.77
1st Support Level 118.38
2nd Support Level 117.03
3rd Support Level 114.66

See More

52-Week High 125.14
Last Price 120.77
Fibonacci 61.8% 106.14
Fibonacci 50% 100.27
Fibonacci 38.2% 94.40
52-Week Low 75.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.